Όλο το DSpace

Πλοήγηση ανά Θέμα "lung diffusion capacity"

Αποτελέσματα 1-6 από 6

    • Clinical relevance of circulating autoantibodies in idiopathic pulmonary fibrosis; A NAt hard to break 

      Kirgou P., Sinis S.I., Dimeas I.E., Papanikolaou I.C., Tatsis K., Gogali A., Gourgoulianis K.I., Bogdanos D.P., Daniil Z. (2022)
      Patients with idiopathic pulmonary fibrosis are screened for circulating autoantibodies as part of the initial interstitial lung disease workup. Management of seropositive idiopathic pulmonary fibrosis is currently considered ...

    • Diabetes mellitus vs. Raynaud disease: Different lung vascular bed disorders 

      Boulbou, M. S.; Gourgoulianis, K. I.; Krommydas, G. C.; Klisiaris, V. K.; Arseniou, A. A.; Dafopoulos, K. C.; Molyvdas, P. A. (2002)
      Background. In type 11 diabetes mellitus there are few data concerning pulmonary function abnormalities. In normal subjects and in patients with primary Raynaud phenomenon, cold pressor test induces a decrease in carbon ...

    • Diet, lung function and swimmers' performance 

      Kokkalis, C. Z.; Athanassaki, M.; Gourgoulianis, K. I.; Molyvdas, P. A. (2001)
      Purpose: The aim of this study was to correlate athletic performance with both lung function and diet. Design: Open, uncontrolled trial. Materials and Methods: Sixty-eight swimmers (28 females and 40 males), 9-15 years ...

    • Efficacy and safety of nintedanib in a greek multicentre idiopathic pulmonary fibrosis registry: A retrospective, observational, cohort study 

      Antoniou K., Markopoulou K., Tzouvelekis A., Trachalaki A., Vasarmidi E., Organtzis J., Tzilas V., Bouros E., Kounti G., Rampiadou C., Kotoulas S.-C., Bardaka F., Bibaki E., Fouka E., Meletis G., Tryfon S., Daniil Z., Papakosta D., Bouros D. (2020)
      Nintedanib is a tyrosine kinase inhibitor approved for the treatment of idiopathic pulmonary fibrosis (IPF). In a retrospective, real-world study across seven Greek hospitals, we evaluated the effectiveness and safety of ...

    • Pulmonary function and circulating adhesion molecules in patients with diabetes mellitus 

      Boulbou, M. S.; Gourgoulianis, K. I.; Petinaki, E. A.; Klisiaris, V. K.; Maniatis, A. N.; Molyvdas, P. A. (2003)
      Background: Lung function in diabetes has been reported in several studies with contradictory results. Diabetes mellitus increases expression of adhesion molecules through hyperglycemia. These molecules play an important ...

    • Pulmonary function testing in COPD: looking beyond the curtain of FEV1 

      Kakavas S., Kotsiou O.S., Perlikos F., Mermiri M., Mavrovounis G., Gourgoulianis K., Pantazopoulos I. (2021)
      Chronic obstructive pulmonary disease (COPD) management remains challenging due to the high heterogeneity of clinical symptoms and the complex pathophysiological basis of the disease. Airflow limitation, diagnosed by ...